Serum vitamin D and parathyroid hormone in relation to cardiac structure and function: the ICELAND-MI substudy of AGES-Reykjavik.
about
Optimal Vitamin D Supplementation Levels for Cardiovascular Disease ProtectionVitamin-D concentrations, cardiovascular risk and events - a review of epidemiological evidence.Vitamin D and cardiovascular disease prevention.Could vitamin D supplements be a new therapy for heart failure? Possible pathogenic mechanisms from data of intervention studies.Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS)Interactions between adrenal-regulatory and calcium-regulatory hormones in human health.Plasma phospholipid PUFAs are associated with greater muscle and knee extension strength but not with changes in muscle parameters in older adults.Aldosterone, parathyroid hormone, and the use of renin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosisSerum uric acid is associated with left ventricular hypertrophy independent of serum parathyroid hormone in male cardiac patients.Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the Multi-Ethnic Study of Atherosclerosis.Plasma phospholipid fatty acids and fish-oil consumption in relation to osteoporotic fracture risk in older adults: the Age, Gene/Environment Susceptibility StudyHypertension, Antihypertensive Medications, and Risk of Incident Primary Hyperparathyroidism.Vitamin D receptor genetics on extracellular matrix biomarkers and hemodynamics in systolic heart failure.Higher Plasma Phospholipid n-3 PUFAs, but Lower n-6 PUFAs, Are Associated with Lower Pulse Wave Velocity among Older Adults.Estimated GFR and Subsequent Higher Left Ventricular Mass in Young and Middle-Aged Adults With Normal Kidney Function: The Coronary Artery Risk Development in Young Adults (CARDIA) StudyVitamin D and the heart.Lower serum 25-hydroxyvitamin D level is associated with impaired myocardial performance and left ventricle hypertrophy in newly diagnosed hypertensive patients.Vitamin D and the cardiovascular system: an overview of the recent literature.Vitamin D: recent advances and implications for athletes.Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study.Angiotensin-Converting Enzyme Inhibition and Parathyroid Hormone SecretionThe fibroblast growth factor-23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk.Parathyroidectomy improves cardiovascular outcome in nondiabetic dialysis patients with secondary hyperparathyroidism.Parathormone Levels Are Independently Associated with the Presence of Left Ventricular Hypertrophy in Patients with Coronary Artery Disease.Associations between Proportion of Plasma Phospholipid Fatty Acids, Depressive Symptoms and Major Depressive Disorder. Cross-Sectional Analyses from the AGES Reykjavik Study.Full normalization of severe hypertension after parathryoidectomy - a case report and systematic review.
P2860
Q26782269-C9F9DDBC-F2A3-4833-802A-DF449F7F32BCQ30234617-388A3806-DA85-4E3A-B5C0-6686CCC5B335Q30251419-CFD8154A-02F6-4EC8-9154-C47DDE5554D1Q30831509-13F3893A-3DA3-4569-9D18-216417100B80Q33654616-0150EA5B-5EEB-4ABD-86DD-C5BF00744F54Q34008136-4AAAE277-104A-45AA-B9E0-0C67447D68FAQ34684182-BF40E835-76B6-4FE7-84FC-4B9F94C9F0A2Q35055052-5338D6A1-10BE-4563-A80F-7CEF5B80A4A0Q35067870-4D5C8FBA-9D03-4FC6-B98A-7AB85B9CABDDQ35115028-EEE068B3-02A9-46EE-9317-B45DFABA00F5Q35537831-DA7F1C82-805A-4A23-9951-99FED078007FQ35680906-09C51E14-175B-475E-83C4-28B3E70CB0ACQ35740866-2F1893B8-EA86-4067-BBB1-4346F51991D1Q36087812-0E012078-0779-478D-B560-9119056DDA58Q36495082-5D7CEE3F-2A1D-4EEC-B1F3-EDE208C2B9DFQ37342339-A93770D7-3C22-424B-BCD4-75D84995389DQ37723833-E40BAFA7-CF38-4554-BF86-47120E371B80Q38152318-59EE9D1A-CD1C-4855-867E-436D2710AFF7Q38253994-D1F4E845-40AA-41FB-BAAA-7312421E65BCQ38954566-D45E0D84-831B-45AC-885C-2CA3F5F71454Q41229697-B0D166E6-7232-428F-ABED-DBA53E031A19Q45134043-F3F16772-C5D6-4C3D-8E69-685EFCEB382AQ48417341-2F56F216-8D42-49ED-A0F2-4E2D3B836347Q51714847-2C43DBD9-222E-4AFC-8C63-5AF9A21E59ABQ51767024-DC4A7854-3B4B-4FF3-83F2-7B2144875FBBQ55318018-D5240D11-88A4-460A-A117-93BDAAE4BC3A
P2860
Serum vitamin D and parathyroid hormone in relation to cardiac structure and function: the ICELAND-MI substudy of AGES-Reykjavik.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Serum vitamin D and parathyroi ...... MI substudy of AGES-Reykjavik.
@en
type
label
Serum vitamin D and parathyroi ...... MI substudy of AGES-Reykjavik.
@en
prefLabel
Serum vitamin D and parathyroi ...... MI substudy of AGES-Reykjavik.
@en
P2093
P2860
P50
P356
P1476
Serum vitamin D and parathyroi ...... MI substudy of AGES-Reykjavik.
@en
P2093
A J van Ballegooijen
G Eiríksdóttir
I A Brouwer
L J Launer
P2860
P304
P356
10.1210/JC.2012-4252
P407
P577
2013-04-12T00:00:00Z